Secondary (metastatic) breast cancer is incurable but treatable. Our nurse empowers patients to access clinical trials that aim to extend and improve the quality of life for patients. Our highly specialist nurse provides individualised 1-2-1 advice, information and support.
Categories
Beneficiaries
Secondary breast cancer is the leading cause of death for UK women under 50, with 1,000 deaths monthly. The five-year survival rate is 22%, and median survival is three years. Patients tell us they feel written off. Clinical trials can extend life, but accessing information is difficult. Only 23% of oncologists discuss trials with patients, and just 32% of patients bring it up themselves.
“Today's cancer treatments were once clinical trials”. Our specialist nurses empower patients to access trials as part of their treatment pathway. They help patients navigate clinical trials, answering questions, guiding UK-wide participation, and conducting personalised trial searches. They support patient-clinician discussions and provide unbiased information, never endorsing specific trials. Recommendations are tailored to each patient’s needs, ensuring informed decisions about trial opti
